Song S T
Academy of Military Medical Sciences, Beijing.
Zhonghua Zhong Liu Za Zhi. 1989 Jan;11(1):19-21.
Results of comparative study of HLA-A, -B typing in 73 patients with breast cancer (BC) who had different ER status and 50 healthy individuals in north China are reported. Of these 73 patients, HLA-C, -DR typing were also studied in 58 patients. The results showed that HLA-Bw61 (40) were negatively associated with BC but -Cw7 and -DRw6 were positively associated with BC. Moreover, -DRw6 was more closely associated with ER(+) status, with a RR value of 8.621. In the ER (-) group, there were no specific related antigens. In the light of the difference in pathology, prognosis and effect of endocrine therapy between ER (+) and ER (-), the authors believe that the two kinds of breast cancer may be a heterogeneous disease.
报告了对中国北方73例具有不同雌激素受体(ER)状态的乳腺癌(BC)患者和50名健康个体进行HLA - A、- B分型的比较研究结果。在这73例患者中,还对58例患者进行了HLA - C、- DR分型。结果显示,HLA - Bw61(40)与乳腺癌呈负相关,而 - Cw7和 - DRw6与乳腺癌呈正相关。此外,- DRw6与ER(+)状态的相关性更强,相对危险度(RR)值为8.621。在ER(-)组中,没有特定的相关抗原。鉴于ER(+)和ER(-)乳腺癌在病理、预后和内分泌治疗效果方面的差异,作者认为这两种乳腺癌可能是一种异质性疾病。